Global Derivatives ADV Up Year-over-Year but
Down Sequentially
European Cash Equities ADV Up Year-over-Year
and Up Sequentially
U.S. Cash ADV Down Year-over-Year and Down
Sequentially
NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for October 20131.
Global derivatives average daily volume (“ADV”) of 6.5 million
contracts, excluding Bclear in October 2013 increased 1.3% compared
to October 2012, but decreased 1.3% from September 2013. U.S.
equity options volumes in October 2013 decreased 2.9% compared to
October 2012, but increased 7.7% sequentially. ADV in U.S. cash
equities declined 4.8% year-over-year and decreased 3.5%
month-over-month. European cash equities ADV in October 2013
increased 8.1% compared to October 2012 and increased 3.0% from
September 2013 levels.
Highlights
- NYSE Euronext global derivatives ADV in
October 2013 of 6.5 million contracts, excluding Bclear increased
1.3% from October 2012, but decreased 1.3% from September 2013
levels.
- NYSE Euronext European derivatives
products ADV in October 2013 of 2.5 million contracts, excluding
Bclear, increased 9.2% compared to October 2012, but decreased
11.3% from September 2013 levels. Including Bclear, NYSE Liffe’s
trade administration and clearing service for OTC products,
European derivatives ADV decreased 7.5% compared to October 2012
and decreased 8.2% from September 2013.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex Options) ADV of 3.9 million contracts in October
2013 decreased 2.9% compared to October 2012 levels, but increased
7.7% from September 2013 levels. NYSE Euronext’s U.S. options
exchanges accounted for 25.0% of total U.S. consolidated equity
options trading in October 2013, down from 28.5% in October 2012
and down from 25.5% in September 2013.
- NYSE Liffe U.S. ADV of approximately
30,000 contracts decreased from 43,700 contracts in October 2012
and decreased from 73,700 contracts in September 2013.
- NYSE Euronext European cash products
ADV of 1.4 million transactions in October 2013 increased 8.1%
compared to October 2012 and increased 3.0% compared to September
2013.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE MKT) handled ADV of 1.5 billion shares in
October 2013 decreased 4.8% compared to October 2012 and decreased
3.5% compared to September 2013. NYSE Euronext’s Tape A matched
market share in October 2013 was 29.4%, down from 30.6% in October
2012 and down from 31.3% in September 2013.
Please click here for the Monthly Transaction Activity Data
Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. For more information, please visit:
http://www.nyx.com.
Please follow us at:Exchanges BlogFacebookLinkedInTwitter
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING
STATEMENTS
This written communication contains “forward-looking statements”
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “may,” “hope,”
“will,” “should,” “expect,” “plan,” “anticipate,” “intend,”
“believe,” “estimate,” “predict,” “potential,” “continue,” “could,”
“future” or the negative of those terms or other words of similar
meaning. You should carefully read forward-looking statements,
including statements that contain these words, because they discuss
our future expectations or state other “forward-looking”
information. Forward-looking statements are subject to numerous
assumptions, risks and uncertainties which change over time. ICE
Group, ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement.
Forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving ICE
Group, ICE and NYSE Euronext, including future financial results,
ICE’s and NYSE Euronext’s plans, objectives, expectations and
intentions, the expected timing of completion of the transaction
and other statements that are not historical facts. Important
factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in
ICE’s and NYSE Euronext’s filings with the U.S. Securities and
Exchange Commission (the “SEC”). These risks and uncertainties
include, without limitation, the following: the inability to close
the merger in a timely manner; the failure to satisfy other
conditions to completion of the merger, including receipt of
required regulatory and other approvals; the failure of the
proposed transaction to close for any other reason; the possibility
that any of the anticipated benefits of the proposed transaction
will not be realized; the risk that integration of NYSE Euronext’s
operations with those of ICE will be materially delayed or will be
more costly or difficult than expected; the challenges of
integrating and retaining key employees; the effect of the
announcement of the transaction on ICE’s, NYSE Euronext’s or the
combined company’s respective business relationships, operating
results and business generally; the possibility that the
anticipated synergies and cost savings of the merger will not be
realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete
than anticipated, including as a result of unexpected factors or
events; diversion of management’s attention from ongoing business
operations and opportunities; general competitive, economic,
political and market conditions and fluctuations; actions taken or
conditions imposed by the United States and foreign governments or
regulatory authorities; and adverse outcomes of pending or
threatened litigation or government investigations. In addition,
you should carefully consider the risks and uncertainties and other
factors that may affect future results of the combined company, as
are described in the section entitled “Risk Factors” in the joint
proxy statement/prospectus filed by ICE Group with the SEC, and as
described in ICE’s and NYSE Euronext’s respective filings with the
SEC that are available on the SEC’s web site located at
www.sec.gov, including the sections entitled “Risk Factors” in
ICE’s Form 10-K for the fiscal year ended December 31, 2012, as
filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE
Euronext’s Form 10-K for the fiscal year ended December 31, 2012,
as filed with the SEC on February 26, 2013. You should not place
undue reliance on forward-looking statements, which speak only as
of the date of this written communication. Except for any
obligations to disclose material information under the Federal
securities laws, ICE Group, ICE and NYSE Euronext undertake no
obligation to publicly update any forward-looking statements to
reflect events or circumstances after the date of this written
communication.
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE
TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. In connection with the proposed transaction,
ICE Group has filed with the SEC a registration statement on Form
S−4, which the SEC has declared effective and which contains a
joint proxy statement/prospectus with respect to the proposed
acquisition of NYSE Euronext by ICE Group. The final joint proxy
statement/prospectus has been delivered to the stockholders of ICE
and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND
NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY
AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH
THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION
REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION.
Investors and security holders may obtain a free copy of the joint
proxy statement/prospectus, as well as other filings containing
information about ICE and NYSE Euronext, without charge, at the
SEC’s website at http://www.sec.gov. Investors may also obtain
these documents, without charge, from ICE’s website at
http://www.theice.com and from NYSE Euronext’s website at
http://www.nyx.com.
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume Total
Volume Average Daily Volume
Total Volume
% Chg vs.
% Chg vs.
(Unaudited; contracts in thousands)
Oct-13
Oct-12
% Chg
Oct-13 Oct-12 %
Chg YTD 2013
YTD 2012
YTD 2013
YTD 2012
Number of Trading Days - European Cash 23 23 23 23 214 214 Number
of Trading Days - European Derivatives 23 23 23 23 215 215 Number
of Trading Days - U.S. Markets 23 21 23 21 211 211
European
Derivatives Products 2,905 3,140 -7.5%
66,819 72,218 -7.5% 3,778 1.8%
812,197 1.3% of which Bclear 394 841 -53.1% 9,063
19,335 -53.1% 657 -49.9% 141,162 -37.7%
Total Fixed
Income Products 1,737 1,523 14.1%
39,953 35,029 14.1% 2,316 29.6%
497,848 29.0% Short Term Interest Rate
Products 1,605 1,383 16.0% 36,919 31,814 16.0% 2,143 30.9% 460,758
30.3%
Medium and Long Term Interest Rate
Products 1
132 140 -5.6% 3,035 3,215 -5.6% 173 15.4% 37,090 14.8%
Total Equity Products 2
1,048 1,511 -30.6% 24,114 34,755
-30.6% 1,367 -25.6% 293,960
-25.9% Individual Equity Products 627 1,107 -43.4%
14,416 25,458 -43.4% 877 -35.4% 188,530 -35.7% Futures 247 715
-65.4% 5,692 16,445 -65.4% 485 -46.5% 104,250 -46.8% Options 379
392 -3.2% 8,724 9,014 -3.2% 392 -13.1% 84,281 -13.5% Equity Index
Products 422 404 4.3% 9,698 9,297 4.3% 490 2.4% 105,429 1.9%
of which Bclear 393 841 -53.2% 9,047 19,335 -53.2% 655 -50.0%
140,893 -37.9% Individual Equity Products 320 778 -58.9% 7,363
17,896 -58.9% 559 -54.2% 120,155 -43.0% Futures 246 710 -65.3%
5,666 16,322 -65.3% 473 -57.1% 101,667 -46.7% Options 74 68 7.9%
1,697 1,573 7.9% 86 -25.9% 18,488 -7.9% Equity Index Products 73 63
17.0% 1,684 1,439 17.0% 96 5.5% 20,737 31.1%
Commodity
Products 120 106 13.0% 2,751
2,434 13.0% 95 6.7% 20,390
6.2% U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts 3,921 4,039 -2.9% 90,192
84,817 6.3% 4,023 3.8% 848,914 4.8% Total Consolidated Options
Contracts 15,684 14,190 10.5% 360,730 297,991 21.1% 14,919 0.8%
3,147,981 1.8% NYSE Group Share of Total 25.0% 28.5% 25.0%
28.5% 27.0% 0.8% 27.0% 0.8%
NYSE Liffe U.S.
Futures and Futures Options Volume* 30.0 43.7 -31.4% 690 1,006
-31.4% 53.2 -29.0% 11,485.7 -29.0%
European Cash Products
(trades in thousands) 1,383 1,279 8.1%
31,804 29,421 8.1% 1,393 -7.5%
298,175 -8.0% Equities 1,338 1,233 8.5% 30,778
28,364 8.5% 1,345 -7.7% 287,814 -8.1% Exchange-Traded Funds 12 12
7.1% 287 267 7.1% 14 -0.1% 2,902 -0.5% Structured Products 28 29
-2.6% 639 656 -2.6% 30 -4.4% 6,450 -4.9% Bonds 4 6 -25.3% 100 133
-25.3% 5 -8.5% 1,009 -9.0%
U.S. Cash Products (shares in
millions) 5
1,461 1,536 -4.8% 33,612 32,251
4.2% 1,520 -11.1% 320,789 -10.3%
NYSE Listed (Tape A) Issues 4 Handled
Volume 5 1,025 1,103 -7.1% 23,565 23,157 1.8% 1,085 -11.4% 228,875
-10.5% Matched Volume 6 991 1,052 -5.8% 22,782 22,083 3.2% 1,046
-9.9% 220,738 -9.0% Total NYSE Listed Consolidated Volume 3,371
3,439 -2.0% 77,524 72,216 7.4% 3,435 -7.5% 724,685 -6.6%
Share of Total Consolidated Volume Handled Volume 5 30.4%
32.1% -1.7% 30.4% 32.1% -1.7% 31.6% -1.4% 31.6% -1.4% Matched
Volume 6 29.4% 30.6% -1.2% 29.4% 30.6% -1.2% 30.5% -0.8% 30.5%
-0.8%
NYSE Arca, MKT and Regional (Tape B) Listed
Issues Handled Volume 5 247 214 15.7% 5,689 4,491 26.7%
251 -0.3% 52,883 0.7% Matched Volume 6 229 198 15.9% 5,274 4,154
27.0% 231 2.0% 48,789 2.9% Total NYSE Arca & MKT Listed
Consolidated Volume 1,059 932 13.6% 24,348 19,567 24.4% 1,088 1.9%
229,540 2.8%
Share of Total Consolidated Volume
Handled Volume 5 23.4% 23.0% 0.4% 23.4% 23.0% 0.4% 23.0% -0.5%
23.0% -0.5% Matched Volume 6 21.7% 21.2% 0.5% 21.7% 21.2% 0.5%
21.3% 0.0% 21.3% 0.0%
Nasdaq Listed (Tape C) Issues
Handled Volume 5 189 219 -13.6% 4,357 4,603 -5.3% 185 -21.3%
39,030 -20.5% Matched Volume 6 168 195 -13.6% 3,872 4,094 -5.4% 165
-18.2% 34,818 -17.4% Total Nasdaq Listed Consolidated Volume 1,885
1,747 7.9% 43,346 36,692 18.1% 1,758 0.3% 371,011 1.3%
Share of Total Consolidated Volume Handled Volume 5 10.1%
12.5% -2.4% 10.1% 12.5% -2.4% 10.5% -2.9% 10.5% -2.9% Matched
Volume 6 8.9% 11.2% -2.3% 8.9% 11.2% -2.3% 9.4% -2.1% 9.4% -2.1%
Exchange-Traded Products 5,7 Handled
Volume 5 233 205 13.8% 5,362 4,300 24.7% 234 -0.6% 49,455 0.3%
Matched Volume 6 216 190 13.9% 4,976 3,990 24.7% 216 1.7% 45,621
2.7% Total ETF Consolidated Volume 1,016 903 12.6% 23,373 18,961
23.3% 1,041 0.9% 219,662 1.8%
Share of Total Consolidated
Volume Handled Volume 5 22.9% 22.7% 0.2% 22.9% 22.7% 0.2% 22.5%
-0.3% 22.5% -0.3% Matched Volume 6 21.3% 21.0% 0.3% 21.3% 21.0%
0.3% 20.8% 0.2% 20.8% 0.2% 1 Data includes currency
products.
2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives. 3 Includes trading in U.S.
equity options contracts, not equity-index options. 4 Includes all
volume executed in NYSE Group crossing sessions. 5 Represents the
total number of shares of equity securities and ETFs internally
matched on the NYSE Group's exchanges or routed to and executed at
an external market center. NYSE Arca routing includes odd-lots. 6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges. 7 Data included in
previously identified categories. * ADVs calculated with the
appropriate number of NYSE Liffe U.S. trading days. Source: NYSE
Euronext, Options Clearing Corporation and Consolidated Tape as
reported for equity securities. All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
NYSE EuronextMedia:Amsterdam, +31-20-550-4488Lisbon,
+351-217-900-029New York, +1-212-656-2411Brussels,
+32-2-509-1392London, +44-20-7379-2789Paris,
+33-1-49-27-11-33orInvestor Relations:New York,
+1-212-656-5700nyx.com
NYSE Group (NYSE:NYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
NYSE Group (NYSE:NYX)
Historical Stock Chart
From Jul 2023 to Jul 2024